Iglynide (Iglinid)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceRepaglinideRepaglinide
Similar drugsTo uncover
  • Diaglinide®
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Iglynide
    pills inwards 
    Pharmasintez-Tyumen, Open Company     Russia
  • Novonorm®
    pills inwards 
    Novo Nordisk A / S     Denmark
    • Dosage form: & nbsppills
    ATX: & nbsp

    A.10.B.X   Other hypoglycemic drugs

    A.10.B.X.02   Repaglinide

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004383
    Date of registration:20.07.2017
    Expiration Date:20.07.2022
    The owner of the registration certificate:Pharmasintez-Tyumen, Open CompanyPharmasintez-Tyumen, Open Company Russia
    Manufacturer: & nbsp
    Illustrated instructions
      Instructions
      Up